Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:44:48 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:TSOI from 2023-05-07 to 2024-05-06 - 24 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-04 09:00U:TSOINews ReleaseTherapeutic Solutions International Granted Patent on Commercially Available QuadraMune(TM) Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
2024-02-29 09:00U:TSOINews ReleaseTherapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
2024-02-26 09:00U:TSOINews ReleaseTherapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiation
2024-01-22 14:58U:TSOINews ReleaseTherapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities
2024-01-16 09:00U:TSOINews ReleaseTherapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy
2024-01-03 09:00U:TSOINews ReleaseTherapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene ¢ „ ¢
2023-12-11 09:00U:TSOINews ReleaseTherapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease
2023-11-27 09:00U:TSOINews ReleaseTherapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression
2023-11-20 09:00U:TSOINews ReleaseTherapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA
2023-10-20 09:00U:TSOINews ReleaseRes Nova Biologics Announces First Cancer Patient Treated with FloraStilbene ¢ „ ¢
2023-10-17 09:00U:TSOINews ReleaseRes Nova Biologics Recruits Abortion Pill Reversal Founder to Scientific Advisory Board
2023-09-29 09:00U:TSOINews ReleaseTherapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils
2023-09-18 09:00U:TSOINews ReleaseTherapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board
2023-09-15 09:00U:TSOINews ReleaseTherapeutic Solutions International Subsidiary Discloses Potential Solution to Immunotherapy Resistance in Cancer by ¢ € œHealing Tumor ¢ €  Before Killing It
2023-09-11 09:00U:TSOINews ReleaseTherapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia
2023-08-21 09:30U:TSOINews ReleaseFloraStilbene ¢ „ ¢ Demonstrates Synergy with Conventional Chemotherapy and Immunotherapy in Reducing Triple Negative Breast Cancer
2023-08-16 08:39U:TSOINews ReleaseTherapeutic Solutions International Subsidiary Allogen Biologics Inc. Successfully Manufactures JadiCell Master Cell Bank to Provide Cells for Right to Try Use and Phase III ARDS Clinical Trial
2023-07-31 09:00U:TSOINews ReleaseTherapeutic Solutions International Prevention Subsidiary Campbell Neurosciences Receives Notice of Allowance on Suicide Prevention Drug Candidate
2023-07-18 09:00U:TSOINews ReleaseTherapeutic Solutions International Subsidiary Res Nova Bio Inc Discovers New Mechanism of Action for Breast Cancer Immunotherapy Adjuvant FloraStilbene ¢ „ ¢
2023-07-12 09:00U:TSOINews ReleaseTherapeutic Solutions International Files for Orphan Drug Designation Use of JadiCell Adult Stem Cells for Treatment of Frontotemporal Dementia
2023-06-26 09:00U:TSOINews ReleaseTherapeutic Solutions International Files for Orphan Drug Designation Using JadiCell Adult Universal Donor Stem Cells for Treatment of Acute Respiratory Distress Syndrome
2023-05-25 09:00U:TSOINews ReleaseTherapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells
2023-05-22 09:00U:TSOINews ReleaseTherapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses
2023-05-15 09:00U:TSOINews ReleaseTherapeutic Solutions International Spin-Off Res Nova Bio Partners with Cure Stat Rx to Manufacture First in Class Breast Cancer Immunotherapy Product FloraStilbene ¢ „ ¢